Virtual Presentation

Toward Individualized Therapies: Metastatic Colorectal Cancer

Source: Clinical Advances in Colorectal Cancer: The Role of Targeted Therapy in the Continuum of Care

Toward Individualized Therapies: Metastatic Colorectal Cancer

Faculty:

Alan P. Venook, MD

CREDIT INFORMATION

Release Date: February 11, 2010

Expiration Date: February 10, 2011

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss current evidence regarding treatment of metastatic colorectal cancer with targeted therapeutic agents
Identify biomarkers with predictive ability in the setting of colorectal cancer
Apply lessons learned from recent clinical trials in the clinical management of patients with colorectal cancer
Compare the efficacy of various combination regimens for the treatment of metastatic colorectal cancer based on patient characteristics and other factors

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.